🇺🇸 FDA
Patent

US 12396988

Methods of using muscarinic antagonists in the treatment of depression

granted A61KA61K31/4245A61K31/439

Quick answer

US patent 12396988 (Methods of using muscarinic antagonists in the treatment of depression) held by The Board of Regents of the University of Texas System expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/4245, A61K31/439, A61K31/44, A61K31/4406